A band that is strongly fluorescent and migrates electrophoretically with serum albumin is commonly found in electrophoretograms of sera from patients with chronic renal failure. We sought to determine whether the fluorescence originates from binding of certain still-unidentified metabolites or drugs, from an abnormal albumin species, or from some other protein entity. Molecular-exclusion On electrophoresis of sera from patients with chronic renal failure a distinct fluorescent band is seen situated close to the creatinekinase BB isoenzyrneor between the MB and the BB isoenzymes (1-7). Studies in which iodoacetate(2) and anti-BB antibodies(3,7) were used to inhibit the enzyme, as well as studiesinwhich the enzyme substrateswere omitted (2) (3) (4) (5) (6) 
spectrum for serum. A fluorescent species with an emission maximum of 415 ± 5 nm, separated by thin-layer chromatography, appears to account for the increased serum fluorescence. On electrophoresis of sera from patients with chronic renal failure a distinct fluorescent band is seen situated close to the creatinekinase BB isoenzyrneor between the MB and the BB isoenzymes (1-7). Studies in which iodoacetate (2) and anti-BB antibodies(3,7) were used to inhibit the enzyme, as well as studiesinwhich the enzyme substrateswere omitted (2) (3) (4) (5) (6) or where the changes in fluorescencewere monitored kinetically(4),provide evidence that the fluorescencein the sera of such patients is not ascribableto enzyme activity. The fluorescent specieshas not yet been identified, nor isitknown whether it is naturally occurring or arisesfrom exogenous dietaryor drug sources.
Some studieshave shown that the fluorescenceispresent in end-stage renal failure (4, 8) ; others indicatethat itoccurs more widely inchronic renalfailure (1, 2, 6) but not in severe, acute renal failure (6, 8) . The fluorescenceordinarilyseen in serum of patients with chronic renal failureappears to decrease with improvement of the disease and after successful renal transplantation
(1, 4, 6, 8 (Mr) in excess of 100 000 (6) . In one study, the material responsible for the fluorescence was precipitated with anti-albumin (9), but in another it was not (6) . The substance appears to be non-dialyzable and it is not believed to be a contaminant of the hemodialysis equipment, because it also is present in sera from patients on peritoneal dialysis (6) . Because the fluorescing material in the serum of patients with chronic renal failurecould be useful in differentiating between acute and chronic renal failure, we attempted to characterize it further and to provide some quantitative information on its relative concentrations in the serum of patients with chronic renal failure. We used molecular-exclusion column chromatography and isoelectric focusing to show that the fluorescence is indeed associated with albumin. Treatment of samples with charcoal and ethanol provided evidence that the fluorescencecomes from ligands bound to albumin. We also describe a preliminary method for isolating the fluorescent material from serum, and discuss its chromatographic properties.
Materials and Methods

Subjects.
We studied 12 each analysis, we layered 10 tL of test serum on the top of the packed column and eluted with phosphate buffer (0.1 molfL, pH 7.2) prepared by mixing appropriate amounts of 0.1 mol/L Na2HPO4 and KH2PO4. A flow rate of about 80 pL/min was maintained throughout the experiment. diluting with water to a total volume of 0.8 mL, adding 9 mg of Norit A charcoal, and mixing with a magnetic stirrer for 1.5 h in a cold room at 4 #{176}C. We removed the charcoal by centrifugation (20 000 X g, 20 mm). We removed the supernate, diluted to 3 mL, and verified the removal of fluorescence by fluorometric analysis as previously described. Fluorescence removal with alcohol. We added 4 mL of absolute ethanol or methanol to 400 zL of serum, shook the mixture for 15 mm on an Eberbach shaker, then centrifuged to precipitate proteins.
Results
Molecular-exclusion chromatography and cellulose acetate electrophoresis.
We examined sera from renal-disease patients and controls by molecular-exclusion chromatography and cellulose acetate electrophoresis, to determine whether the fluorescence seen by fluorometric emission spectroscopy is associated with serum albumin (Table 1) Because fluorescence increases and albumin generally decreases in sera of patients with chronic renal failure, values for both the P-200 and the electrophoretic method are expressed in terms of albumin. The albumin-bound fluorescence separated by gel-filtration was 2.24-fold that of the normal individuals; however, when expressed on an albumin basis, the difference between renalpatientsand normals is3.50-fold (Table 1) . As a result, the means-and presumably diagnostic sensitivity-between disease and non-disease are more distinct. With the electrophoretic method, the mean fluorescence intensities of albumin from renal-disease patients were 3.04-fold those for normals; when calculated on an albumin basis, they were 3.47-fold greater.
Isoelectric focusing.
Observations of the polyacrylamide gel patterns after isoelectric focusing further support the contention that the fluorescence is associated with albumin.
The two fluorescent bands observed immediately after isoelectric focusing corresponded in position to the two albumin bands seen after staining. from a renal-disease patient displayed fluorescence associated with both albumin bands. The relative fluorescence intensities of the albumin-associated bands were not quantitated by scanning fluorometry, but the patterns from 10 patients with renal disease were correctly distinguished from the patterns for five normal persons by an individual who was uninformed as to the patient status.
Removal of fluorescence with charcoal and alcohol. Results of the three methods provide evidence that the fluorescence seen in serum is associated only with albumin, because it is unlikely that a fluorescent species distinct from albumin would migrate with albumin on electrophoresis, display the same two isoelectric points as albumin, and yet have the same molecular-exclusion chromatographic properties.
Even though it appeared likely that the fluorescence was due to a ligand bound to albumin, structural alterations in the albumin molecule could be the cause of the increased fluorescence. Albumin does fluoresce naturally (10) and, in uremic patients, there are changes in the amino acid composition of albumin (12), in the ratios of the two albumin bands found after isoelectric focusing (12, 13) , in the alpha-helix content U4), and in the drug-binding properties (11) (12) (13) . We therefore performed experiments with charcoal and with ethanol to investigate which of the two possibilities is responsible for the fluorescence.
We first examined the effect of pH on serum fluorescence stability and found that it did not change between pH 3 and 12, but declined rapidly at values <3 or >12. The loss in fluorescence is irreversible: the fluorescence is not restored by readjusting the pH of the samples to neutral. With charcoal present, a lowering of pH from 7.5 to 3.0 increased the removal of fluorescence from serum, from 25.7% to 50.7%. This decrease in fluorescence was not the result of pH quenching, because a corresponding sample treated identically, except without charcoal, was used to establish total fluorescence. Also, the decreased fluorescence was not caused by adsorption of protein on charcoal, as determined by protein analysis of the supernatant phase. Our attempts to desorb the fluorescent material from charcoal with methanol were not successful, but we could remove a constant proportion of the fluorescence from serum with a simple alcohol precipitation of protein, 4 mL of ethanol or methanol being added to 400 zL of serum. The samples were mixed for 15 mm, centrifuged, and the fluorescence spectra were determined on the resulting alcohol-aqueous phase. Emission maxima for the samples from renal patients were at 415 (range 5 nm) and the fluorescence intensities of the ethanol extracts correlated with that of serum (y = 0.31x Fluorescence spectra of metabolites.
We checked the fluorescence spectra of several vitamins and a number of metabolites that are known to increase with renal disease: uric acid, urea, creatinine, $-phenylpyruvic acid, methyl guanidine, 
